Teleflex Is Expanding Its Portfolio of Surgical and Interventional Devices

Over the past decade, Teleflex has transformed from a diverse industrial, commercial, and healthcare company to one focused on single-use medical devices for surgical and minimally invasive procedures. It has relied heavily on acquisitions and divestitures and is likely to remain acquisitive in future. It generally targets companies with revenue in the $50 million-$300 million range to expand its portfolio and footprint. The firm prioritizes the development and acquisition of relatively inexpensive devices—generally under $1,000—that are unlikely to be targeted by healthcare device intermediaries for cost-savings. As an example, one night's stay in a hospital can lead to billed expenses of over $10,000, with Teleflex’s products accounting for around $500, or 5% of the total hospital cost.